Search for dissertations about: "cytochrome P4501A2"

Found 3 swedish dissertations containing the words cytochrome P4501A2.

  2. 1. Metabolism of melatonin : with focus on the influence of cytochrome P4501A2

    Author : Carina Ursing; Karolinska Institutet; Karolinska Institutet; []
    Keywords : Melatonin; cytochrome P450 1A2 ; fluvoxamine; caffeine; tobacco smoke.;

    Abstract : Melatonin (MT) regulates circadian rhythms. It is produced by pinealocytes. Their function is regulated by light. MT enters the blood stream by passive diffusion. READ MORE

  4. 2. Clinical and experimental studies of organ-specific autoimmune diseases : With special reference to Addison's disease and autoimmune hepatitis : by Gennet Gebre-Medhin

    Author : Gennet Gebre-Medhin; Uppsala universitet; []
    Keywords : Medical sciences; Addison s Disease; replacement therapy; DHEA; autoimmune hepatitis; APS I; autoantigen; cytochrome P4501A2; aromatic L-amino acid decarboxylase; MEDICIN OCH VÅRD; MEDICINE; MEDICIN; Medicine; medicin;

    Abstract : Organ-specific autoimmunity constitutes a large health problem, where both the clinical management and our understanding of the pathogenetic mechanisms need to improve. Women with Addison's disease have abnormally low levels of dehydroepiandrosterone (DHEA), its sulphate ester (DHEA-S) and androgens relative to age, and many patients complain of physical and mental fatigue and low stress tolerance. READ MORE

  5. 3. Organ-specific autoantibodies in Addison's disease and autoimmune polyendocrine syndrome type I

    Author : Annika Söderbergh; Uppsala universitet; []
    Keywords : Medical sciences; Addison s disease; APS I; Down syndrome; AIRE; autoantibodies; autoantigens; autoimmunity; MEDICIN OCH VÅRD; MEDICINE; MEDICIN; Medicine; medicin;

    Abstract : Assessment of autoantibodies is a valuable tool in the diagnostic procedure of autoimmune diseases. The aim of this study was to investigate the prevalence of different autoantibodies and their associations with disease manifestations in patients with Addison's disease and autoimmune polyendocrine syndrome type I (APS I). READ MORE